Related Experiment Video
Updated: May 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Indications, Management, and Short- and Medium-Term Outcomes of Patients with Chronic Coronary Occlusion Treated with
Lucia Barbieri1, Gabriele Tumminello1, Lorenzo Mafrici2
1Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Insights
Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) is a challenging procedure. This study shows PCI for CTO has a high success rate and low complication incidence in real-world practice.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Chronic total occlusion (CTO) is a complete coronary artery blockage for ≥3 months.
- CTO diagnosis is challenging, and it can be asymptomatic.
- Indications for CTO recanalization lack randomized controlled trial support.
Purpose of the Study:
- To assess indications, management, and procedural outcomes of percutaneous revascularization (PCI) for CTO.
- To ensure a uniform patient population regarding technologies and methods.
- To evaluate the safety and efficacy of CTO PCI in a real-world setting.
Main Methods:
- Retrospective analysis of 41 consecutive patients undergoing PCI for CTO.
- Data collected from January 2021 to 2024.
- Outcomes included procedural success, mortality, major adverse cardiovascular events, and residual symptoms, with a median follow-up of 449 days.
Main Results:
- High success rate for PCI in CTO recanalization.
- Low incidence of major complications observed.
- Favorable outcomes regarding mortality and major adverse cardiovascular events.
Conclusions:
- Real-world data confirm PCI for CTO is a high-success, low-complication procedure.
- Further research may be warranted to solidify indications based on robust evidence.
- CTO PCI is a viable option for selected patients.
Abstract:
The diagnosis of chronic total occlusion (CTO), characterized by the complete obstruction of a coronary artery for at least three months, remains challenging and can be entirely asymptomatic. Since the indications for performing a recanalization procedure for CTO do not originate from randomized controlled trials, this study aimed to assess the indications, management, and procedural outcomes of patients undergoing percutaneous revascularization (PCI) for a CTO, ensuring that the population was as uniform as possible regarding technologies and methodological approaches. Forty-one consecutive patients who underwent PCI for CTO recanalization were enrolled from January 2021 to 2024. Additional outcomes included mortality, major adverse cardiovascular events, and the presence of residual cardiac symptoms, with a median follow-up of 449 days and an interquartile range of 230-643 days. Our real-life study confirmed that PCI for CTO has a high success rate and a low incidence of major complications.
Related Concept Videos
Pericarditis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care

